Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting
Francesco A. GrecoiD, Andreas KrämeriD, Laurenz WahliD, Lewis ElsoniD, Theresa A. L. Ehret, Joshua Gerninghaus, Janina Möckel, Susanne MülleriD, Thomas HankeiD, Stefan KnappiD
Abstract
Casein kinase-2 (CK2) are serine/threonine kinases with dual co-factor (ATP and GTP) specificity, that are involved in the regulation of a wide variety of cellular functions. Small molecules targeting CK2 have been described in the literature targeting different binding pockets of the kinase with a focus on type I inhibitors such as the recently published chemical probe SGC-CK2-1. In this study, we investigated whether known allosteric inhibitors binding to a pocket adjacent to helix D could be combined with ATP mimetic moieties defining a novel class of ATP competitive compounds with a unique binding mode. Linking both binding sites requires a chemical linking moiety that would introduce a 90-degree angle between the ATP mimetic ring system and the D targeting moiety, which was realized using a sulfonamide. The synthesized inhibitors were highly selective for CK2 with binding constants in the nM range and low micromolar activity. While these inhibitors need to be further improved, the present work provides a structure-based design strategy for highly selective CK2 inhibitors.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 0.69
- Field percentile
- top 37%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proposed allosteric inhibitors bind to the ATP site of CK2α
Paul Brear, Darby Ball, … Marko Hyvonen·Journal of Medicinal ChemistryPeer-reviewed·Oct 29, 2020
- Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library
D. Mudaliar, R. H. Mansky, … R. Gomez-Pastor·bioRxiv·Jan 18, 2024
- Optimization of pyrazolopyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor
A. Kraemer, C. G. Kurz, … T. Hanke·bioRxiv·Jun 27, 2020
- Development of allosteric, selective cyclin-dependent kinase 2 (CDK2) inhibitors that are negatively cooperative with cyclin binding and show potential as contraceptive agents
E. B. Faber, J. Tang, … G. I. Georg·bioRxiv·Jun 30, 2022
- Discovery of an IKK2 Site that Allosterically Controls Its Activation
S. J. Hotchkiss, M. C. Mulero, … G. Ghosh·bioRxiv·Jan 27, 2021
- Structural and binding studies of human CAMKK2 kinase domain bound to small molecule ligands
G. S. Profeta, C. V. dos Reis, … R. M. Counago·bioRxiv·Feb 1, 2019